Dalteparin Versus Vitamin K Antagonists for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer and Renal Impairment- Pharmacoeconomic Analysis of a Prospective Randomized Trial
Abstract
Authors
G Dranitsaris LG Shane S Woodruff G Feugere M Crowther